China's CanSino in mRNA vaccine deal with AstraZeneca | Business Information & News | Westlaw

China's CanSino in mRNA vaccine deal with AstraZeneca | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, China's CanSino in mRNA vaccine deal with AstraZeneca, Business Information & News
8/8/23 REUTERS 11:35:10
REUTERS
Copyright (c) 2023 Thomson Reuters
August 8, 2023
China's CanSino in mRNA vaccine deal with AstraZeneca
Casey Hall
Miyoung Kim
Himani Sarkar
Mark Potter
Ludwig Burger; Frankfurt
SHANGHAI (Reuters) -CanSino Biologics has agreed with AstraZeneca to provide "contract development and manufacturing services" to support the Anglo-Swedish drugmaker's messenger RNA (mRNA) vaccine programme, the Chinese company said on Tuesday.
In a...
---- Index References ----
Company: CanSino Biologics Inc.; ASTRAZENECA PLC; CSPC PHARMACEUTICAL GROUP LIMITED
News Subject: (Emerging Market Countries (1EM65); Health & Family (1HE30))
Industry: (Coronavirus (1CV19); Drugs (1DR89); Healthcare (1HE06); Infectious Diseases (1IN99); Pharmaceuticals (1PH33); Pharmaceuticals & Biotechnology (1PH13); Vaccines (1VA57); Viral (1VI15))
Region: (Asia (1AS61); China (1CH15); Eastern Asia (1EA61); Far East (1FA27))
Language: EN
Other Indexing: (Communist Party; CanSino Biologics; AstraZeneca; CSPC Pharmaceutical Group)
Keywords: Covid19
Word Count: 318
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.